Aspen Pharmacare Holdings (JSE:APN) Cash Flow for Dividends: R-941 Mil (TTM As of Dec. 2025)


JSE:APN Aspen Pharmacare Holdings Ltd JSE:APN
73 GF Score
Price R155.95
GF Value R178.17
Valuation Modestly Undervalued
! 10 Warning Signs
View Full Analysis

What is Aspen Pharmacare Holdings Cash Flow for Dividends?

Aspen Pharmacare Holdings JSE:APN +0.71% 73 Cash Flow for Dividends is R-941 Mil as of Dec. 2025. GuruFocus rates JSE:APN with a GF Score™ of 73/100 and a GF Value™ of R178.17 (Modestly Undervalued). The stock has 10 warning signs investors should review.

Aspen Pharmacare Holdings's cash flow for dividends for the six months ended in Dec. 2025 was R-941 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in Dec. 2025 was R-941 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Aspen Pharmacare Holdings's quarterly payment of dividends declined from Dec. 2024 (R-1,601 Mil) to Jun. 2025 (R0 Mil) but then increased from Jun. 2025 (R0 Mil) to Dec. 2025 (R-941 Mil).

Aspen Pharmacare Holdings's annual payment of dividends increased from Jun. 2023 (R-1,455 Mil) to Jun. 2024 (R-1,525 Mil) and increased from Jun. 2024 (R-1,525 Mil) to Jun. 2025 (R-1,601 Mil).

Aspen Pharmacare Holdings Cash Flow for Dividends Related Terms

Aspen Pharmacare Holdings Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Aspen Pharmacare Holdings's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aspen Pharmacare Holdings Cash Flow for Dividends Chart

Aspen Pharmacare Holdings Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Cash Flow for Dividends
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -1,196.00 -1,455.00 -1,525.00 -1,601.00

Aspen Pharmacare Holdings Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Cash Flow for Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,525.00 0.00 -1,601.00 0.00 -941.00
JSE:APN
73GF Score
Aspen Pharmacare Holdings Ltd JSE:APN
Cash Flow for Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aspen Pharmacare Holdings Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

Cash Flow for Dividends for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was R-941 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of R-941 Mil mean?
Aspen Pharmacare Holdings (JSE:APN) has a Cash Flow for Dividends of R-941 Mil as of Dec. 2025. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Aspen Pharmacare Holdings and its competitors.
Is Aspen Pharmacare Holdings' Cash Flow for Dividends too high?
Aspen Pharmacare Holdings' current Cash Flow for Dividends is R-941 Mil. Overall, Aspen Pharmacare Holdings has a GF Score™ of 73/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Aspen Pharmacare Holdings' Cash Flow for Dividends compare to ZTS and UTHR?
Aspen Pharmacare Holdings' Cash Flow for Dividends of R-941 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Drug Manufacturers company?
A good Cash Flow for Dividends depends on the Drug Manufacturers industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Aspen Pharmacare Holdings and its competitors. Aspen Pharmacare Holdings's current Cash Flow for Dividends is R-941 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aspen Pharmacare Holdings stock overvalued right now?
Based on GuruFocus' analysis, Aspen Pharmacare Holdings (JSE:APN) is currently considered Modestly Undervalued. The stock's GF Value™ is R178.17, compared to a current price of R155.95 — trading 12.5% below its estimated fair value. The current Cash Flow for Dividends is R-941 Mil. Aspen Pharmacare Holdings' overall GF Score™ is 73/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Aspen Pharmacare Holdings (JSE:APN), the current Cash Flow for Dividends is R-941 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Aspen Pharmacare Holdings (JSE:APN) Overvalued in 2026?

Based on GuruFocus' analysis, Aspen Pharmacare Holdings stock appears to be undervalued. The current stock price of R155.95 is trading 12.5% below its estimated GF Value™ of R178.17. GuruFocus considers Aspen Pharmacare Holdings to be Modestly Undervalued.

Key valuation signals for JSE:APN:

  • Cash Flow for Dividends: R-941 Mil
  • GF Value™: R178.17 vs. price of R155.95 (12.5% below fair value)
  • GF Score™: 73/100 with 10 warning signs

No single metric tells the full story. See the JSE:APN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Aspen Pharmacare Holdings Business Description

Address Douglas Saunders Drive, Aspen Place, 9 Rydall Vale Park, La Lucia Ridge, Durban, NL, ZAF
Aspen Pharmacare Holdings Ltd is a multinational pharmaceutical company. The group focuses on marketing and manufacturing a broad range of post-patent, branded medicines and domestic brands covering both hospital and consumer markets. The business segments of the group are split between the Commercial Pharmaceuticals and Manufacturing segments. The Commercial Pharmaceuticals business segments are: Injectables, Over-the-counter, and Prescription. The Manufacturing business segments are: Active Pharmaceutical Ingredients, Finished Dose Form, and Heparin. Its geographic regions are Africa Middle East, Europe CIS, Australasia, Asia, and America.
73GF Score

Get the complete analysis for JSE:APN

Cash Flow for Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

R155.95
Price
R178.17
GF Value